Abbott (NYSE: ABT) and BG Medicine, Inc. announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott’s ARCHITECT immunochemistry instrument platform, specifically the company’s i1000SR and i2000SR instruments. The agreement grants Abbott a [...]

NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, has announced that it is collaborating with the Broad Institute of MIT and Harvard to investigate molecular networks involved in immune response and other important biological processes. The three-year collaboration is also designed to explore ways to expand how NanoString’s [...]

Jill M. Siegfried, Ph.D., co-director of the University of Pittsburgh Cancer Institute’s (UPCI) Lung and Thoracic Malignancies Program, has received a $1 million grant from the V Foundation for Cancer Research, an organization founded by ESPN and Jim Valvano, former legendary basketball coach of North Carolina State University. The grant will help support the establishment [...]

The mainstay immune system protein TRAF6 plays an unexpected, key role activating a cell signaling molecule that in mutant form is associated with cancer growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the Aug. 28 edition of Science.

The amino acids and minerals found in asparagus extract may alleviate alcohol hangover and protect liver cells against toxins, according to a study in the Journal of Food Science, published by the Institute of Food Technologists.